Amoéba is a greentech company whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial scale and cultivating it in sufficient volumes to offer biological solutions that constitute a viable alternative to the chemical products widely used today. Amoéba is currently focusing on the global biocontrol market for plant protection and on the cosmetics market.

Employees

Sector

Agricultural Chemicals

More about the company

Quotes

Date	Price	Change	Volume
26-08-28	€0.6940	+0.87%	102,458
26-08-27	€0.6880	-1.71%	121,454
26-08-26	€0.7000	-0.71%	39,085
26-08-25	€0.7050	-0.56%	83,896
26-08-24	€0.7090	+3.05%	83,937

Real-time Euronext Paris

More quotes

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.6940EUR

Average target price

1.400EUR

Spread / Average Target

+101.73%

Consensus

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Market Closed - Euronext Paris 11:55:00 2026-08-28 EDT			5-day change	1st Jan Change
0.6940 ^EUR	+0.87%		+0.87%	-34.40%

07-23	Amoéba and Koppert Extends Distribution Agreement for Axpera Technology and Reaffirm Their Shared Ambitions in the Field of Innovative Biofungicides	CI
07-01	Amoéba Receives Marketing Authorization For Biofungicide AXPERA In France	CI

Market Cap	47.81M 55.48M 44.82M 40.92M 77.08M 5.3B 77.33M 532M 207M 2.68B 208M 204M 8.88B	P/E 2026 *	-9.25x	P/E 2027 *	69.4x
Enterprise Value	58.96M 68.42M 55.28M 50.46M 95.06M 6.54B 95.36M 656M 256M 3.3B 257M 251M 10.95B	EV / Sales 2026 *	11.6x	EV / Sales 2027 *	3.84x
Free-Float	87.09%	Yield 2026 *	-	Yield 2027 *	-

07-23	Amoéba and Koppert Extends Distribution Agreement for Axpera Technology and Reaffirm Their Shared Ambitions in the Field of Innovative Biofungicides	CI
07-01	Amoéba Receives Marketing Authorization For Biofungicide AXPERA In France	CI
06-30	Amoéba gains from marketing authorization in France
06-30	Amoéba Bags Marketing Approval for Biofungicide in France	MT
06-30	Amoéba wins marketing authorization in France
06-08	Amoéba S.A. Obtains 120-Day Emergency Authorization for Use of Biofungicide AXPERA Against Basil Downy Mildew in Italy	CI
06-08	Amoéba secures strategic emergency authorization in Italy
05-06	Amoéba Announces Two New Exceptional Trial Permits for Biocontrol Solution in the Netherlands	CI
04-28	Amoéba Announces Emergency Authorization for Axpera Biocontrol Solution	CI
04-28	Amoéba secures emergency authorization for downy mildew treatment in France
04-13	Amoéba and Koppert Highlight the Potential of Axpera Technology in Brazil for Strategic Crops	CI
03-26	Amoéba Raises EUR7 Million via Private Placement	MT
03-26	Amoëba successfully completes capital increase

07-23	Amoéba : Amoéba and Koppert extend their distribution agreement for AXPERA technology and reaffirm their shared ambitions in the field of innovative biofungicides	AT
07-01	Amoéba has received marketing authorization in France for its biofungicide AXPERA	GL
06-30	Amoéba : Amoéba has received marketing authorization in France for its biofungicide AXPERA	AT
06-08	Amoéba : Amoéba obtains in Italy a 120 day emergency authorization for the use of its biofungicide AXPERA against basil downy mildew	AT
05-06	Amoéba : Two new exceptional trial permits in the Netherlands in 2026 for Amoéba’s biocontrol solution	AT

Amoéba Stock

Stocks

ALMIB

FR0011051598

Agricultural Chemicals

Valuation : Amoéba

Chart: Amoéba

Latest news : Amoéba

Press Releases : Amoéba

News in other languages : Amoéba

Quotes and Performance

Price Extremes

Managers and Directors : Amoéba

Latest insider transactions

Pesticide

Financials

Company Profile

Quotes

Analysts' Consensus

Annual profits - Rate of surprise

07-23	Amoéba : Amoéba et Koppert étendent la durée de leur accord de distribution pour la technologie AXPERA et confirment leurs ambitions communes dans les biofongicides innovants
07-01	Amoéba verkrijgt in Frankrijk een vergunning voor het in de handel brengen van zijn biofungicide AXPERA
07-01	Amoéba ottiene l’autorizzazione all'immissione in commercio in Francia per il suo biofungicida AXPERA
07-01	Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA
07-01	Amoéba obtiene la autorización de comercialización en Francia para su biofungicida AXPERA

1 day	+0.87%
1 week	+0.87%
Current month	-3.07%
1 month	+2.06%
3 months	-22.89%
6 months	-32.62%
Current year	-34.40%

1 week	0.68	0.71
1 month	0.67	0.74
Current year	0.62	1.12
1 year	0.62	1.2
3 years	0.36	1.44
5 years	0.36	1.8
10 years	0.36	34.93

Manager	Title	Age	Since
Dominique Jean Francois Marie Doucet CEO	Chief Executive Officer	60	2023-12-13
Sandrine Troussieux CTO	Chief Tech/Sci/R&D Officer	-	2018-08-31
Jean-Baptiste Eberst LAW	General Counsel	-	2015-06-30

Director	Title	Age	Since
Valérie Filiatre BRD	Director/Board Member	-	2014-05-31
Benoît Villers CHM	Chairman	70	2023-12-13
Jean-luc Souche BRD	Director/Board Member	70	2023-05-24

Date	Insider	Type	Main position	Quantity	% Market Cap.
6/30/26	Benoît Villers	Sell	Chairman	-31,100	0.0400%
5/23/25	Dominique Jean Francois Marie Doucet	Fiscal year	Chief Executive Officer	40,000	0.0805%
5/22/25	Dominique Jean Francois Marie Doucet	Fiscal year	Chief Executive Officer	560,000	1.1277%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMOÉBA	+0.87%	+0.87%	-23.82%	+21.54%	55.48M
JIANGSU YANGNONG CHEMICAL CO., LTD.	+3.18%	+3.40%	-22.63%	-12.00%	3.39B
ZHEJIANG XINAN CHEMICAL INDUSTRIAL GROUP CO.,LTD	+2.20%	+4.80%	+5.00%	+8.27%	2.23B
ADAMA LTD.	+1.42%	+3.06%	-18.05%	-27.41%	1.91B
LIER CHEMICAL CO.,LTD.	+1.48%	-1.51%	+12.00%	+9.44%	1.71B
CAC NANTONG CHEMICAL CO., LTD.	-2.03%	+2.50%	-19.97%	-	1.65B
SHENZHEN NOPOSION CROP SCIENCE CO., LTD.	+0.38%	+14.46%	-15.29%	+61.01%	1.55B
ANHUI GUANGXIN AGROCHEMICAL CO., LTD.	+0.97%	+3.26%	-12.20%	-48.06%	1.41B
NANTONG JIANGSHAN AGROCHEMICAL & CHEMICALS CO.,LTD.	+2.34%	+3.83%	-24.18%	-13.56%	1.23B
LIMIN GROUP CO.,LTD.	-0.43%	+11.11%	-18.39%	+94.24%	1.14B
Average	+1.04%	+5.17%	-13.75%	+10.39%	1.63B
Weighted average by Cap.	+1.35%	+5.28%	-12.61%	+4.09%

	2026 *	2027 *
Net sales	5.1M 5.92M 4.78M 4.37M 8.22M 566M 8.25M 56.73M 22.13M 286M 22.22M 21.74M 947M	15.55M 18.05M 14.58M 13.31M 25.07M 1.72B 25.15M 173M 67.49M 871M 67.75M 66.28M 2.89B
Net income	-5.2M -6.03M -4.88M -4.45M -8.38M -577M -8.41M -57.84M -22.57M -291M -22.66M -22.16M -965M	550K 638K 516K 471K 887K 61M 890K 6.12M 2.39M 30.79M 2.4M 2.34M 102M
Net Debt	11.15M 12.94M 10.45M 9.54M 17.98M 1.24B 18.04M 124M 48.39M 624M 48.58M 47.52M 2.07B	11.85M 13.75M 11.11M 10.14M 19.11M 1.31B 19.17M 132M 51.43M 663M 51.63M 50.51M 2.2B